Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Kreuz

Showing results (11-20 of 66) with videos related to

Pageof 7
Sort By:
The Journal of Urology|September 28, 2011
Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinomaJimsgene Sanjmyatav, Kerstin Junker, Sophie Matthes, et al.
Genes, Chromosomes & Cancer|June 30, 2016
Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell LymphomasClaudia Otto, René Scholtysik, Roland Schmitz, et al.
International Journal of Cancer|January 4, 2012
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomasRené Scholtysik, Inga Nagel, Markus Kreuz, et al.
BMC Cancer|April 25, 2008
MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European CaucasiansJoerg Bittenbring, Frédérique Parisot, Alain Wabo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphomaChristina Heemann, Markus Kreuz, Irene Stoller, et al.
Cancer Research|March 11, 2010
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphomaMarion Hoffmann, Markus A Schirmer, Mladen V Tzvetkov, et al.
Haematologica|March 24, 2018
Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2Heike Horn, Christian Kohler, Raphael Witzig, et al.
Oncotarget|January 9, 2013
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patientsBirgit Schif, Jochen K Lennerz, Christian W Kohler, et al.
Cancers|August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant MelanomaStefanie Meyer, Diana Handke, Anja Mueller, et al.
International Journal of Molecular Sciences|August 7, 2021
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor TherapyRobin Reschke, Philipp Gussek, Andreas Boldt, et al.
Pageof 7

Showing results (11-20 of 66) with videos related to

Sort By:
Pageof 7
The Journal of Urology|September 28, 2011
Identification of genomic alterations associated with metastasis and cancer specific survival in clear cell renal cell carcinomaJimsgene Sanjmyatav, Kerstin Junker, Sophie Matthes, et al.
Genes, Chromosomes & Cancer|June 30, 2016
Novel IGH and MYC Translocation Partners in Diffuse Large B-Cell LymphomasClaudia Otto, René Scholtysik, Roland Schmitz, et al.
International Journal of Cancer|January 4, 2012
Recurrent deletions of the TNFSF7 and TNFSF9 genes in 19p13.3 in diffuse large B-cell and Burkitt lymphomasRené Scholtysik, Inga Nagel, Markus Kreuz, et al.
BMC Cancer|April 25, 2008
MDM2 gene SNP309 T/G and p53 gene SNP72 G/C do not influence diffuse large B-cell non-Hodgkin lymphoma onset or survival in central European CaucasiansJoerg Bittenbring, Frédérique Parisot, Alain Wabo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 11, 2012
Circulating levels of TNF receptor II are prognostic for patients with peripheral T-cell non-Hodgkin lymphomaChristina Heemann, Markus Kreuz, Irene Stoller, et al.
Cancer Research|March 11, 2010
A functional polymorphism in the NAD(P)H oxidase subunit CYBA is related to gene expression, enzyme activity, and outcome in non-Hodgkin lymphomaMarion Hoffmann, Markus A Schirmer, Mladen V Tzvetkov, et al.
Haematologica|March 24, 2018
Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2Heike Horn, Christian Kohler, Raphael Witzig, et al.
Oncotarget|January 9, 2013
SOCS1 mutation subtypes predict divergent outcomes in diffuse large B-Cell lymphoma (DLBCL) patientsBirgit Schif, Jochen K Lennerz, Christian W Kohler, et al.
Cancers|August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant MelanomaStefanie Meyer, Diana Handke, Anja Mueller, et al.
International Journal of Molecular Sciences|August 7, 2021
Distinct Immune Signatures Indicative of Treatment Response and Immune-Related Adverse Events in Melanoma Patients under Immune Checkpoint Inhibitor TherapyRobin Reschke, Philipp Gussek, Andreas Boldt, et al.
Pageof 7